BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 9, 2000
View Archived Issues
Positive interim phase I/II data shown for Multikine in head and neck cancer
Read More
HumaRAD pilot clinical results reported for head and neck cancer
Read More
Cypress Bioscience expands Prosorba Column pilot program
Read More
MSI-ipratropium trial reveals efficacy of new delivery system
Read More
Insulin and sildenafil restore gastrointestinal function in diabetic mice
Read More
Suppression of mitochondrial respiration linked to osteoarthritis
Read More
Chemotherapy of head and neck cancer enhanced by gene therapy
Read More
Tamoxifen plus cisplatin improves survival in melanoma patients
Read More
CNS-reactive human MAbs promote remyelination in MS model
Read More
Genasense receives orphan drug status for treatment of malignant melanoma
Read More
MediChem-AstraZeneca collaboration extended
Read More
Phase II study of clenoliximab in rheumatoid arthritis begins
Read More
Collateral expands research collaboration with NYU
Read More
Sankyo develops rosiglitazone analogues with hypoglycemic activities
Read More
Novel growth factor receptor inhibitors described by Sugen
Read More
Prous Science selected official internet and multimedia provider for XXII ESC Congress
Read More
Pulmicort Respules approved in U.S. for children aged 1 to 8 years
Read More
New peptides under development at Ludwig Institute
Read More
Roche discloses new series of IP receptor agonists
Read More
New antiangiogenic agents under development at Merck KGaA
Read More
Nycomed Imaging describes new compounds as contrast media
Read More
MTP inhibitors under development at Janssen
Read More
New polypeptides useful for treatment of metastases
Read More
Kogenate Bayer approved in E.U. for hemophilia A
Read More